Burak Altintas, MD, an orthopedist with UTMB, who was not involved in this study, further highlighted the following limitations of the research: The limitations include retrospective design and likely residual confounding despite matching as fracture risk is influenced by many variables that are not reported [] Further, the comparison group is heterogeneous, combining another GLP-1 receptor agonist (dulaglutide) with two mechanistically different weight-loss medications
Recent reviews and meta-analyses have reported that high MD compliance is associated with a significant reduction in chronic disease risk (171)
A: FDA-approved medications have undergone rigorous testing for safety, efficacy, and quality
Shape and biomechanical characteristics of human red blood cells in health and disease
Weight management to reduce spinal load
Cest un concept nouveau de chirurgie de la silhouette, qui utilise des instruments dont nous ne nous servons pas en chirurgie